寡核苷酸
化学
单体
组合化学
计算生物学
核酸
药品
DNA
生物化学
化学改性
化学稳定性
计算机科学
药理学
作者
Seetha S. Krishnamoorthy,Molly S. Blevins,Steven Chin,Yi‐Ju Tseng,Jinsen Chen,Xiaoshuai Fan,Yongfeng Yang,Andrew Watkins,Jeff Cheng-Wei Lin,Aditi Dubey,Sumit Mahajan,Han Nguyen,Kayon Colao,Santhosh Kumar Thatikonda
摘要
vitro snake venom phosphodiesterase (SVPD) assays demonstrated that Cp-modified ASOs exhibit significantly enhanced nuclease resistance over the unmodified parent sequence, sometimes providing near-complete protection. This differential effect on stability and potency across the different oligonucleotide lengths and modalities warrants further investigation to fully delineate the mechanism of action of these modifications and to further optimize their application in therapeutic oligonucleotide design. Here, based on these results, we propose Cp monomers as a novel class of molecules for oligonucleotide therapeutic applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI